JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 18, 2005
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
280/7/5892    most recent
M404751200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, F.
Right arrow Articles by Cole, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, F.
Right arrow Articles by Cole, G. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print December 7, 2004
J. Biol. Chem, 10.1074/jbc.M404751200
Submitted on April 28, 2004
Revised on December 6, 2004
Accepted on December 7, 2004

Curcumin inhibits formation of Abeta oligomers and fibrils and binds plaques and reduces amyloid in vivo

F. Yang, G. P. Lim, A. N. Begum, O. J. Ubeda, M. R. Simmons, S. S. Ambegaokar, P. P. Chen, R. Kayed, C. G. Glabe, S. A. Frautschy, and G. M. Cole

GRECC (VA Medical) and Medicine, University of California Los Angeles, North Hills, CA 91343

Corresponding Author: gmcole{at}ucla.edu

Alzheimer's disease (AD) involves amyloid (Abeta ) accumulation, oxidative damage and inflammation, and risk is reduced with increased antioxidant and anti-inflammatory consumption. The phenolic yellow curry pigment curcumin has potent anti-inflammatory and antioxidant activities and can suppress oxidative damage, inflammation, cognitive deficits, and amyloid accumulation. Since the molecular structure of curcumin suggested potential Aß-binding, we investigated whether its efficacy in AD models could be explained by effects on Aß aggregation. Under aggregating conditions in vitro, curcumin inhibited aggregation (IC50 =0.8 µM) as well as disaggregated fibrillar Aß40 (IC50 =1 µM), indicating favorable stoichiometry for inhibition. Curcumin was a better Abeta 40 aggregation inhibitor than ibuprofen and naproxen, and prevented Abeta 42 oligomer formation and toxicity between 0.1-1.0 mu M. Under electron microscopy, curcumin decreased dose-dependently Aß fibril formation beginning with 0.125 µM. Curcumin's effects did not depend on Abeta sequence but on fibril-related conformation. AD and Tg2576 mice brain sections incubated with curcumin revealed preferential labeling of amyloid plaques. In vivo studies showed that curcumin injected peripherally into aged Tg mice, crossed the blood brain barrier and bound plaques. When fed to aged Tg2576 mice with advanced amyloid accumulation, curcumin labeled plaques and reduced amyloid levels and plaque burden. Hence, curcumin directly binds small ß-amyloid species to block aggregation and fibril formation in vitro and in vivo. These data suggest that low dose curcumin effectively disaggregates Aß as well as prevents fibril and oligomer formation, supporting the rationale for curcumin use in clinical trials preventing or treating AD.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W.-h. Wu, P. Lei, Q. Liu, J. Hu, A. P. Gunn, M.-s. Chen, Y.-f. Rui, X.-y. Su, Z.-p. Xie, Y.-F. Zhao, et al.
Sequestration of Copper from {beta}-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents
J. Biol. Chem., November 14, 2008; 283(46): 31657 - 31664.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. L. Kim, B. Zhang, I. P. Mills, M. E. Milla, K. R. Brunden, and V. M.-Y. Lee
Effects of TNF{alpha}-Converting Enzyme Inhibition on Amyloid {beta} Production and APP Processing In Vitro and In Vivo
J. Neurosci., November 12, 2008; 28(46): 12052 - 12061.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
R. Robert, O. Dolezal, L. Waddington, M. K. Hattarki, R. Cappai, C. L. Masters, P. J. Hudson, and K. L. Wark
Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers
Protein Eng. Des. Sel., October 16, 2008; (2008) gzn052v1.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. A. Fradinger, B. H. Monien, B. Urbanc, A. Lomakin, M. Tan, H. Li, S. M. Spring, M. M. Condron, L. Cruz, C.-W. Xie, et al.
C-terminal peptides coassemble into A{beta}42 oligomers and protect neurons against A{beta}42-induced neurotoxicity
PNAS, September 16, 2008; 105(37): 14175 - 14180.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. N. Begum, M. R. Jones, G. P. Lim, T. Morihara, P. Kim, D. D. Heath, C. L. Rock, M. A. Pruitt, F. Yang, B. Hudspeth, et al.
Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 196 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Kim, T. G. Son, H. R. Park, M. Park, M.-S. Kim, H. S. Kim, H. Y. Chung, M. P. Mattson, and J. Lee
Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus
J. Biol. Chem., May 23, 2008; 283(21): 14497 - 14505.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q.-L. Ma, F. Yang, F. Calon, O. J. Ubeda, J. E. Hansen, R. H. Weisbart, W. Beech, S. A. Frautschy, and G. M. Cole
p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis
J. Biol. Chem., May 16, 2008; 283(20): 14132 - 14143.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. Amit, Y. Avramovich-Tirosh, M. B. H. Youdim, and S. Mandel
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
FASEB J, May 1, 2008; 22(5): 1296 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
C. Riemer, M. Burwinkel, A. Schwarz, S. Gultner, S. W. F. Mok, I. Heise, N. Holtkamp, and M. Baier
Evaluation of drugs for treatment of prion infections of the central nervous system
J. Gen. Virol., February 1, 2008; 89(2): 594 - 597.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. K. Sandur, M. K. Pandey, B. Sung, K. S. Ahn, A. Murakami, G. Sethi, P. Limtrakul, V. Badmaev, and B. B. Aggarwal
Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism
Carcinogenesis, August 1, 2007; 28(8): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Necula, R. Kayed, S. Milton, and C. G. Glabe
Small Molecule Inhibitors of Aggregation Indicate That Amyloid beta Oligomerization and Fibrillization Pathways Are Independent and Distinct
J. Biol. Chem., April 6, 2007; 282(14): 10311 - 10324.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
K. Garai, R. Sureka, and S. Maiti
Detecting Amyloid-{beta} Aggregation with Fiber-Based Fluorescence Correlation Spectroscopy
Biophys. J., April 1, 2007; 92(7): L55 - L57.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Wu, Z. Wu, P. Butko, Y. Christen, M. P. Lambert, W. L. Klein, C. D. Link, and Y. Luo
Amyloid-{beta}-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans
J. Neurosci., December 13, 2006; 26(50): 13102 - 13113.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. L. Masters and K. Beyreuther
Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A{beta} amyloid pathway
Brain, November 1, 2006; 129(11): 2823 - 2839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Yan, X. Hu, H. Song, K. Yin, R. J. Bateman, J. R. Cirrito, Q. Xiao, F. F. Hsu, J. W. Turk, J. Xu, et al.
Matrix Metalloproteinase-9 Degrades Amyloid-beta Fibrils in Vitro and Compact Plaques in Situ
J. Biol. Chem., August 25, 2006; 281(34): 24566 - 24574.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Nishina, H. Kimura, A. Sekiguchi, R.-h. Fukumoto, S. Nakajima, and S. Furukawa
Lysophosphatidylethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAPK
J. Lipid Res., July 1, 2006; 47(7): 1434 - 1443.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Chalovich, J.-h. Zhu, J. Caltagarone, R. Bowser, and C. T. Chu
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
J. Biol. Chem., June 30, 2006; 281(26): 17870 - 17881.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Malm, M. Ort, L. Tahtivaara, N. Jukarainen, G. Goldsteins, J. Puolivali, A. Nurmi, R. Pussinen, T. Ahtoniemi, T.-K. Miettinen, et al.
beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits
PNAS, June 6, 2006; 103(23): 8852 - 8857.
[Abstract] [Full Text] [PDF]


Home page
JWatch GeneralHome page
Curry Inhibits Alzheimer-Like Plaque, in Mice
Journal Watch (General), March 15, 2005; 2005(315): 6 - 6.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.